Chart documentation by general physicians of the glaucoma medications taken by their patients

American Journal of Ophthalmology

Volumn 140, Issue 2, 2005, Pages 344-345

  Jampel, Henry D ^a,c   Parekh, Parag ^a   Johnson, Elizabeth ^b   Miller, Rhonda ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c Maumenee B 117 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CARBONATE DEHYDRATASE INHIBITOR; PROSTAGLANDIN;

ADULT; AGED; CONFIDENCE INTERVAL; FEMALE; GLAUCOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATIENT; PHYSICIAN; PRIORITY JOURNAL; REVIEW;

EID: 23744456875     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2005.02.041     Document Type: Article

References (6)

1. P.J. Lama Systemic adverse effects of beta-adrenergic blockers an evidence-based assessment Am J Ophthalmol 134 2002 749 760
2. J.S. Schuman Short- and long-term safety of glaucoma drugs Expert Opin Drug Saf 1 2002 181 194
3. D.A. Sica Current concepts of pharmacotherapy in hypertension - ophthalmically administered beta blockers and their cardiopulmonary effects J Clin Hypertens (Greenwich) 3 2001 175 178
4. G.D. Novack, M.J. O'Donnell, D.W. Molloy New glaucoma medications in the geriatric population efficacy and safety J Am Geriatr Soc 50 2002 956 962
5. I. Blaufarb, T.M. Pfeifer, W.H. Frishman Beta-blockers. Drug interactions of clinical significance Drug Saf 13 1995 359 370
6. W.H. Frishman, M. Kowalski, S. Nagnur, S. Warshafsky, D. Sica Cardiovascular considerations in using topical, oral, and intravenous drugs for the treatment of glaucoma and ocular hypertension focus on beta-adrenergic blockade Heart Dis 3 2001 386 397